<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00695084</url>
  </required_header>
  <id_info>
    <org_study_id>CIMSTrial</org_study_id>
    <secondary_id>PP1395</secondary_id>
    <nct_id>NCT00695084</nct_id>
  </id_info>
  <brief_title>Constraint-Induced (CI) Movement Therapy for Progressive Multiple Sclerosis (MS)</brief_title>
  <official_title>Constraint-Induced Movement Therapy Trial for Progressive Multiple Sclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Multiple Sclerosis Society</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Multiple Sclerosis Society</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial will evaluate whether progressive multiple sclerosis associated with hemiparesis
      may benefit from Constraint-Induced Movement Therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Constraint-Induced Movement Therapy was developed to treat stroke hemiparesis. Due to the
      similarity between multiple sclerosis and stroke in terms of chronic motor deficit, this
      trial will attempt to determine whether multiple sclerosis may benefit similarly from
      Constraint-Induced Movement Therapy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2007</start_date>
  <completion_date type="Actual">April 2008</completion_date>
  <primary_completion_date type="Actual">April 2008</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement on the Motor Activity Log</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvement on the Wolf Motor Function Test</measure>
    <time_frame>Pre to post-treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">7</enrollment>
  <condition>Multiple Sclerosis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment with Constraint-Induced Movement Therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Constraint-Induced Movement Therapy</intervention_name>
    <description>Intensive practice with the hemiparetic arm for 30 contact hours</description>
    <arm_group_label>1</arm_group_label>
    <other_name>CI Therapy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic upper extremity motor deficit due to multiple sclerosis

        Exclusion Criteria:

          -  Relapse within 3 months of planned enrollment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Victor W Mark, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35249</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 9, 2008</study_first_submitted>
  <study_first_submitted_qc>June 10, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 11, 2008</study_first_posted>
  <last_update_submitted>June 10, 2008</last_update_submitted>
  <last_update_submitted_qc>June 10, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 11, 2008</last_update_posted>
  <responsible_party>
    <name_title>Patricia O'Looney</name_title>
    <organization>National Multiple Sclerosis Society</organization>
  </responsible_party>
  <keyword>multiple sclerosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Multiple Sclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

